Skip to main content

Volume 18 Supplement 1

Proceedings from NextGen Therapies for SJIA & MAS – 2019

Proceedings

Publication of this supplement has been supported by the SJIA Foundation. The article has undergone the journal's standard peer review process for supplements. CS is the Editor-in-Chief of Pediatric Rheumatology. No other competing interests were declared.

Bethesda, MD, USA3-4 October 2019

Conference website

Edited by Charles Spencer.

  1. For reasons poorly understood, and despite the availability of biological medications blocking IL-1 and IL-6 that have markedly improved overall disease control, children with Systemic Juvenile Idiopathic Arth...

    Authors: Scott W. Canna, Grant S. Schulert, Adriana de Jesus, Alex Pickering, Hermine Brunner, Massimo Gadina, Stewart Levine, Raphaela Goldbach-Mansky, Jonathan Boutelle, Rashmi Sinha, Fabrizio DeBenedetti and Alexei Grom
    Citation: Pediatric Rheumatology 2020 18(Suppl 1):53

Official journal of

Annual Journal Metrics

  • 2022 Citation Impact
    2.5 - 2-year Impact Factor
    3.0 - 5-year Impact Factor
    1.035 - SNIP (Source Normalized Impact per Paper)
    0.732 - SJR (SCImago Journal Rank)

    2022 Speed
    10 days submission to first editorial decision for all manuscripts (Median)
    108 days submission to accept (Median)

    2022 Usage 
    901,346 downloads
    750 Altmetric mentions